Anti-VPAC1 antibody Rabbit monoclonal

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Features and Benefits

Evaluate our antibodies with complete peace of mind. If the antibody does not perform in your application, we will issue a full credit or replacement antibody. Learn more.

General description

Vasoactive intestinal peptide (VIP) receptors 1 and 2, termed VPAC1 and VPAC2, are members of the 7 transmembrane G protein-coupled receptor family. Both receptors bind to VIP and pituitary adenylate cyclase-activating polypeptide (PACAP). Interaction of VIP and VPAC1 inhibit megakaryocyte proliferation and induces proplatelet formation. VPAC1 is expressed in subset of mononuclear cells and it is highly expressed in some lung adenocarcinoma.

Immunogen

Synthetic peptide derived from human VPAC1 protein.

Physical form

0.1 ml rabbit monoclonal antibody purified by protein A/G in PBS/1% BSA buffer pH 7.6 with less than 0.1% sodium azide.